Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TransMedics (TMDX) Other Non Operating Income (2018 - 2026)

TransMedics has reported Other Non Operating Income over the past 8 years, most recently at $3.7 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 93.84% year-over-year to $3.7 million; the TTM value through Dec 2025 reached $12.7 million, changed 0.22%, while the annual FY2025 figure was $12.7 million, 0.22% changed from the prior year.
  • Other Non Operating Income for Q4 2025 was $3.7 million at TransMedics, up from $3.2 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $5.0 million in Q3 2023 and troughed at -$1.1 million in Q3 2022.
  • A 5-year average of $1.8 million and a median of $2.2 million in 2023 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: tumbled 558.48% in 2022 and later surged 564.31% in 2023.
  • Year by year, Other Non Operating Income stood at -$345000.0 in 2021, then skyrocketed by 414.49% to $1.1 million in 2022, then surged by 348.39% to $4.9 million in 2023, then crashed by 60.62% to $1.9 million in 2024, then soared by 93.84% to $3.7 million in 2025.
  • Business Quant data shows Other Non Operating Income for TMDX at $3.7 million in Q4 2025, $3.2 million in Q3 2025, and $3.1 million in Q2 2025.